Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / Nevada

Peptide legality · Nevada · updated 2026-09-21

Are peptides legal in Nevada?

Restricted

Peptide therapy is legal in Nevada for FDA-approved medicines prescribed by a licensed clinician, but Nevada is more restrictive than most states because its State Board of Pharmacy has expressly prohibited both 503A and 503B pharmacies from compounding semaglutide and tirzepatide injection products.

Legal status overview

Peptide therapy is legal in Nevada for FDA-approved medicines prescribed by a licensed clinician, but the state takes a more restrictive posture than most because its State Board of Pharmacy has expressly barred compounding of semaglutide and tirzepatide injections. Approved medicines such as Wegovy® (semaglutide) and Zepbound® (tirzepatide) remain available with a valid prescription. Non-approved research peptides such as BPC-157 and TB-500 cannot be lawfully compounded under federal law. This is general information, not legal or medical advice.

Key points

  • FDA-approved peptide medicines such as Wegovy® (semaglutide), Zepbound® (tirzepatide), and Ozempic® (semaglutide) remain legal in Nevada with a valid prescription. [7]
  • The Nevada State Board of Pharmacy issued a licensee notice (dated June 2, 2025) prohibiting the compounding, dispensing, and distribution of semaglutide and tirzepatide injection products by both 503A and 503B facilities. [1]
  • Continuing to compound, dispense, or distribute these products after the effective dates violates Nevada law, including NRS 639.100, NRS 639.233, and NAC 639.593. [2]
  • The Board directive followed FDA declaratory orders removing tirzepatide (December 19, 2024) and semaglutide (February 21, 2025) from the national shortage list, with 503B facilities required to stop after May 22, 2025. [2]
  • BPC-157 is not FDA-approved; not a generic; not evaluated by the FDA, and cannot be lawfully compounded under Section 503A. It was removed from FDA Category 2 on April 15, 2026 but not cleared for compounding. [3]
  • TB-500 (thymosin beta-4) is not FDA-approved and is treated by the FDA as a bulk substance with safety concerns, so it cannot be lawfully compounded. [4]
  • Growth hormone (somatropin) is prescription-only and not a controlled substance, but federal law makes distribution for non-medical uses such as bodybuilding a felony. [5]
  • Nevada has not banned peptide therapy as a category; approved medicines remain available through licensed prescribers and pharmacies, and states may regulate above the federal floor. [6]

Compound-by-compound status

BPC-157
Restricted
Not FDA-approved; not a generic; not evaluated by the FDA. Cannot be lawfully compounded under Section 503A. Removed from FDA Category 2 on April 15, 2026 but not moved to Category 1.
GLP-1 class (semaglutide, tirzepatide)
Restricted
Approved brands such as Wegovy® (semaglutide) and Zepbound® (tirzepatide) are legal with a prescription. The Nevada State Board of Pharmacy expressly prohibits 503A and 503B compounding of semaglutide and tirzepatide injections; compounded versions are not FDA-approved; not a generic; not evaluated by the FDA.
TB-500 (thymosin beta-4)
Restricted
Not FDA-approved; not a generic; not evaluated by the FDA. Classed by the FDA as a bulk substance with safety concerns and not eligible for 503A compounding.
Growth hormone (somatropin)
Legal
Prescription-only and not a controlled substance. FDA-approved for defined medical indications; federal law criminalizes distribution for non-medical uses.

Frequently asked questions

Are peptides legal in Nevada?

FDA-approved peptide medicines are legal in Nevada with a valid prescription. Nevada is stricter than most states because its Board of Pharmacy prohibits compounding of semaglutide and tirzepatide injections. This is general information, not advice.

Can a Nevada pharmacy compound semaglutide or tirzepatide?

No. The Nevada State Board of Pharmacy has prohibited both 503A and 503B pharmacies from compounding, dispensing, or distributing semaglutide and tirzepatide injection products.

Is BPC-157 legal in Nevada?

BPC-157 is not FDA-approved and cannot be lawfully compounded under Section 503A. Its removal from FDA Category 2 in April 2026 did not clear it for compounding.

Can I still get an approved GLP-1 medicine in Nevada?

Yes. Approved brands such as Wegovy® (semaglutide) and Zepbound® (tirzepatide) remain available with a valid prescription; only compounded versions are barred by the Board directive.

Is growth hormone legal in Nevada?

Somatropin is prescription-only and not a controlled substance, but federal law makes distribution for non-medical purposes a felony. A licensed clinician must prescribe it for an approved indication.

General information based on the sourced research above, not legal advice. For a specific situation in Nevada, consult a licensed attorney familiar with pharmaceutical law.